ARTICLE | Clinical News
Macromol oral delivery technology: Starting Phase II trials
May 23, 1994 7:00 AM UTC
Cortecs International Ltd. (DLVRY), U.K. Product: Macromol oral delivery technology for salmon calcitonin, an inhibitor of osteoclasts, the cells that mediate bone breakdown Indication: Osteoporosis a...